Načítá se...
Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti–PD-L1 to eliminate melanoma in mice
Successful cancer immunotherapy entails activation of innate immune receptors to promote dendritic cell (DC) maturation, antigen presentation, up-regulation of costimulatory molecules, and cytokine secretion, leading to activation of tumor antigen-specific cytotoxic T lymphocytes (CTLs). Here we scr...
Uloženo v:
Vydáno v: | Proc Natl Acad Sci U S A |
---|---|
Hlavní autoři: | , , , , , , , , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
National Academy of Sciences
2018
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6140543/ https://ncbi.nlm.nih.gov/pubmed/30150374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1809232115 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|